Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IG Compliance Guide Will Change PBM Rebate Policies, AdvancePCS Says

Executive Summary

The HHS Inspector General's compliance guide for pharmaceutical manufacturers will "push" pharmacy benefit management companies to reform their drug rebate policies, AdvancePCS CEO David Halbert suggested at the SG Cowen health care conference in Boston March 19

You may also be interested in...



Medco Injunction Means Switches Have “Consequences,” Prosecutor Says

The Medco injunction reflects the principle that pharmacy benefit management companies should be responsible for the "consequences" of therapeutic interchange, Associate U.S. Attorney James Sheehan said during a May 11 teleconference sponsored by Pharma Audioconferences

Medco Injunction Means Switches Have “Consequences,” Prosecutor Says

The Medco injunction reflects the principle that pharmacy benefit management companies should be responsible for the "consequences" of therapeutic interchange, Associate U.S. Attorney James Sheehan said during a May 11 teleconference sponsored by Pharma Audioconferences

PBM Contracts Should Focus On Net Cost, Not Rebates, Express Scripts Says

Drug plans should focus on PBMs' abilities to lower overall net cost of prescriptions, rather than try to get a share of manufacturer rebates, Express Scripts Senior VP Thomas Boudreau told a Federal Trade Commission hearing on health care competition June 26 in Washington, D.C

Related Content

UsernamePublicRestriction

Register

PS041484

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel